Summit Therapeutics plc (SMMT): Price and Financial Metrics
SMMT Price/Volume Stats
| Current price | $19.03 | 52-week high | $33.89 |
| Prev. close | $18.19 | 52-week low | $2.10 |
| Day low | $18.33 | Volume | 2,589,400 |
| Day high | $19.39 | Avg. volume | 2,424,191 |
| 50-day MA | $18.72 | Dividend yield | N/A |
| 200-day MA | $13.34 | Market Cap | 14.03B |
SMMT Stock Price Chart Interactive Chart >
Summit Therapeutics plc (SMMT) Company Bio
Summit Therapeutics plc operates as a biopharmaceutical company primarily in the United Kingdom and the Unites States. It focuses on the discovery, development, and commercialization of novel medicines to treat the Duchenne Muscular Dystrophy (DMD), a fatal muscle wasting disease; and infections caused by Clostridium difficile bacteria (CDI). The company was founded in 2003 and is based in Abingdon, England.
SMMT Price Returns
| 1-mo | 3.42% |
| 3-mo | -10.28% |
| 6-mo | 91.06% |
| 1-year | 427.15% |
| 3-year | 749.55% |
| 5-year | N/A |
| YTD | 6.64% |
| 2024 | 583.72% |
| 2023 | -38.59% |
| 2022 | 57.99% |
| 2021 | -42.77% |
| 2020 | 193.75% |
Continue Researching SMMT
Here are a few links from around the web to help you further your research on Summit Therapeutics plc's stock as an investment opportunity:Summit Therapeutics plc (SMMT) Stock Price | Nasdaq
Summit Therapeutics plc (SMMT) Stock Quote, History and News - Yahoo Finance
Summit Therapeutics plc (SMMT) Stock Price and Basic Information | MarketWatch
Loading social stream, please wait...